Meeting the inherent challenges of complex drug substances

Uncategorised Leave a Comment

Realizing the full potential of a novel injectable drug compound is no small task. In the months and years that lead from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can slow development to a halt, often at key stages.

A careful, systematic approach to identifying where and why these roadblocks can occur is fundamental to staying on course. Just as important is a robust, repeatable process design focused on retaining the stability of a compound as it moves through clinical development. The early-stage data captured during this period can play a valuable role in an efficient transition from lab to clinic to market.

Download Vetter’s whitepaper on Anticipating success: Meeting the inherent challenges of complex drug substances to find out more.

Leave a Reply

Your email address will not be published. Required fields are marked *